Short description
Cytosorbents develops therapeutic devices used in purifying blood to treat life-threatening diseases.
Description
CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Each polymer bead contains millions of pores and channels that can be modified to remove substances as small as drugs, to substances as large as antibodies.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Monmouth Junction, New Jersey, United States, North America
Founded on
January 1, 1997
Exited on
August 18, 2006
Went public on
August 18, 2006
Stock symbol
CTSO
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$1230 - 4560
Sign in for full access
Investors
Cannot Access, Noaccess, Noaccess
Sign in for full access
Founders
Frank Clark